| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/14/2007 | EP1751089A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | EP1750712A2 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | CN1914185A Piperazino photoinitiation sensitisers |
| 02/14/2007 | CN1914152A New compounds, methods for their preparation and use thereof |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/14/2007 | CN1911919A Method of coproducing N-methyl morpholine and morpholine |
| 02/14/2007 | CN1911505A Catalyst required for coproducing N-methyl morpholine and morpholine |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176308 Purification; chemical synthesis; photosensitive coloring material; use for coating an optical disc for copy-protection |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176240 Such as 5-fluoro-2-propylpentanoic acid for improving GABA (gamma-aminobutyric acid) receptor responses; treatment of neurodegenerative diseases |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176210 Cannabinoid receptor ligands and uses thereof |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents |
| 02/08/2007 | WO2007016139A2 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene |
| 02/08/2007 | WO2007015805A1 1-amino linked compounds |
| 02/08/2007 | WO2007015533A1 Amidine compound and herbicide |
| 02/08/2007 | US20070032664 Making intermediates such as ((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-ethyl}-2-phenyl-[1,3]dioxan-4-yl)-acetic acid methyl ester for the synthesis of calcium atorvastatin (Lipitor(reg)) |
| 02/08/2007 | US20070032663 Intermediate in the synthesis of calcium atorvastatin (Lipitor(reg)) comprising an amine salt of a carboxylic acid, for example 2-(morpholinocarbonyl)ethylamine, phenylacetic acid salt |
| 02/08/2007 | US20070032662 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide |
| 02/08/2007 | US20070032532 Hsp90 family protein inhibitors |
| 02/08/2007 | US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 02/08/2007 | US20070032472 Reacting a 4-morpholinyl aniline with R-epichlorohydrin; carbonylating to form (a chloromethyloxazolidinone; reacting with potassium phthalimide or aziding; forming free amine with hydrazine hydate, which may be amidated with acetic anhydride; oxazolidinone and 3-chloro-2-hydroxypropyl intermediates |
| 02/08/2007 | US20070031729 Ionic liquids, electrolyte salts for electrical storage devices, liquid electrolytes for electrical storage devices, electrical double-layer capacitors, and secondary batteries |
| 02/08/2007 | CA2617146A1 Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene |
| 02/08/2007 | CA2616383A1 Novel benzo [d] [1,3]-dioxol derivatives |
| 02/07/2007 | EP1749826A1 Process of producing bepromoline |
| 02/07/2007 | EP1749825A1 Process of producing amorolfine |
| 02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2007 | CN1910167A Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
| 02/07/2007 | CN1910144A Sulfonamide derivatives for the treatment of diseases |
| 02/07/2007 | CN1910141A Diamino alcohols and their use as renin inhibitors |
| 02/07/2007 | CN1910135A Amino alcohol derivatives and their activity as renin inhibitors |
| 02/07/2007 | CN1907984A Compound for preparing intermediate for synthesis of atorvastatin calcium |
| 02/07/2007 | CN1907954A Water-soluble derivative of anesthetic 2,6-diisopropyl phenol and preparation method thereof |
| 02/07/2007 | CN1298699C Method for preparing alkoxyamines from nitroxides |
| 02/07/2007 | CN1298698C Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7172650 Capable of subjecting a natural rubber latex to a high-level proteolyzation or deproteinization treatment and can also impart sufficient coagulation properties |
| 02/06/2007 | CA2411961C Novel process for the preparation of pyrazolopyrimidinones |
| 02/01/2007 | WO2007012983A2 Process of producing amorolfine |
| 02/01/2007 | WO2005115969A8 Method for producing quaternary ammonium compounds |
| 02/01/2007 | US20070027187 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |
| 02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
| 02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 02/01/2007 | US20070023628 Labeling agents for mass spectrometry comprising tertiary amines |
| 02/01/2007 | CA2616224A1 10-substituted tetracyclines and methods of use thereof |
| 02/01/2007 | CA2616160A1 Process of producing bepromoline |
| 01/31/2007 | EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/31/2007 | EP1747194A1 Process for producing urethane (meth)acrylates and new urethane (meth)acrylates |
| 01/31/2007 | EP1747193A1 Benzonitrile derivatives to treat musculoskeletal frailty |
| 01/31/2007 | EP1747187A1 Method for the continuous production of an amine |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297543C Substitued arylketones |
| 01/31/2007 | CN1297535C Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/25/2007 | WO2007009299A1 Optically pure n',n'-di substituted -prolylhydrazines as well as the preparation and use thereof |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021473 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/24/2007 | EP1746091A1 Process for the preparation of 2-substituted 2-[-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one citrate |
| 01/24/2007 | EP1745114A1 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate |
| 01/24/2007 | EP1745056A2 Enantioselective phosphoramidite compounds and catalysts |
| 01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
| 01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
| 01/24/2007 | EP1745010A1 Substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1745002A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1744755A2 Compounds and compositions as cathepsin s inhibitors |
| 01/24/2007 | EP1472217B1 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1296362C Process for preparing dimethomoph |
| 01/24/2007 | CN1296356C CCR-3 receptor antagonists VII |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166738 viricides; polymerase inhibitors; therapy for genetic engineered virus |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |